Carlisle Companies Incorporated (CSL)

Debt-to-capital ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 2,463,300 2,762,900 3,004,300 2,859,300 2,829,000 2,923,800 3,032,000 3,058,300 3,024,400 3,041,700 2,875,100 2,678,600 2,629,500 2,544,800 2,417,900 2,411,800 2,537,700 2,475,300 2,516,200 2,518,500
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $2,463,300K)
= 0.00

The debt-to-capital ratio of Carlisle Companies Incorporated has consistently remained at 0.00 over the past several quarters, up to December 31, 2024. This indicates that the company has not used debt financing to fund its operations or investments relative to its total capital structure.

A debt-to-capital ratio of 0.00 implies that the company's capital structure is predominantly composed of equity rather than debt. Companies with lower debt-to-capital ratios are often considered less risky because they have lower financial leverage and are less dependent on debt for operations. In Carlisle Companies' case, maintaining a debt-to-capital ratio of 0.00 may suggest a conservative approach to managing its capital structure and financial risk.

Investors and stakeholders typically view a low debt-to-capital ratio favorably as it reflects financial stability and a lower probability of default. However, it is essential to consider that carrying no debt may limit the company's financial flexibility in taking advantage of growth opportunities or managing cash flow fluctuations in the future.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-capital ratio
Carlisle Companies Incorporated
CSL
0.00
West Pharmaceutical Services Inc
WST
0.00